Loading data
RDCMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 71.49 m USD | 61.01 m USD | 51.6 m USD | 46.05 m USD | 40.28 m USD |
| Cost of revenue | 17.19 m USD | 15.75 m USD | 13.77 m USD | 12.71 m USD | 11.42 m USD |
| Gross profit | 54.3 m USD | 45.26 m USD | 37.83 m USD | 33.34 m USD | 28.86 m USD |
| Research and development expense | 20.24 m USD | 18.66 m USD | 19.58 m USD | 21.48 m USD | 20.35 m USD |
| Operating profit | 8.3 m USD | 3.09 m USD | -662 k USD | -4.11 m USD | -5.49 m USD |
| Profit before tax | 12.59 m USD | 7.2 m USD | 3.9 m USD | -2.1 m USD | -5.14 m USD |
| Income tax expense | 595 k USD | 234 k USD | 182 k USD | 159 k USD | 124 k USD |
| Net income (reported basis) | 11.99 m USD | 6.97 m USD | 3.71 m USD | -2.26 m USD | -5.26 m USD |
| Net income attributable to common shareholders | 11.99 m USD | 6.97 m USD | 3.71 m USD | -2.26 m USD | -5.26 m USD |
| Basic earnings per share | 0.74 USD/share | 0.44 USD/share | 0.25 USD/share | -0.16 USD/share | -0.37 USD/share |
| Diluted earnings per share | 0.71 USD/share | 0.43 USD/share | 0.24 USD/share | -0.16 USD/share | -0.37 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.